• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织因子途径抑制剂在动脉粥样硬化中的表达

Tissue factor pathway inhibitor expression in atherosclerosis.

作者信息

Drew A F, Davenport P, Apostolopoulos J, Tipping P G

机构信息

Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Victoria, Australia.

出版信息

Lab Invest. 1997 Oct;77(4):291-8.

PMID:9354763
Abstract

Tissue factor pathway inhibitor (TFPI) is a potent inhibitor of tissue factor (TF) -initiated coagulation and may play a role in regulating coagulation in atherosclerotic plaques. The expression of TFPI protein and mRNA was examined by immunohistology and in situ hybridization in normal human and rabbit arteries, in human carotid arteries with advanced atherosclerosis, and in atherosclerotic aortas from cholesterol-fed rabbits. In normal human and rabbit arteries, TFPI protein and mRNA were detected in the adventitial layer but were undetectable in the luminal endothelium. In the medial smooth muscle layer of rabbits, weak expression of TFPI mRNA, but not protein, was detected; in that of humans, neither TFPI mRNA nor protein was detectable. In atherosclerotic arteries, TFPI protein and mRNA were detected in three of six internal carotid plaques from patients undergoing endarterectomy, and mRNA alone was detected in one further specimen. TFPI protein was found in areas of the plaque where TF was abundant and colocalized with macrophages, suggesting that these cells are responsible for TFPI synthesis. TFPI protein and mRNA were also detected in fatty-streak lesions in 18 of 19 rabbits fed a high-cholesterol diet for periods between 4 and 16 weeks. In these macrophage-rich lesions, expression of TFPI protein and mRNA was most intense at the base of the plaques. These studies suggest that TFPI is expressed in the adventitial layer of large arteries and that in atherosclerotic vessels, TFPI is expressed by macrophages in focal areas throughout the plaque. Local production of TFPI may regulate procoagulant activity and thrombotic events within atherosclerotic plaques.

摘要

组织因子途径抑制物(TFPI)是组织因子(TF)启动的凝血过程的强效抑制剂,可能在调节动脉粥样硬化斑块中的凝血作用中发挥作用。通过免疫组织化学和原位杂交技术,检测了正常人和兔动脉、晚期动脉粥样硬化的人颈动脉以及高胆固醇喂养兔的动脉粥样硬化主动脉中TFPI蛋白和mRNA的表达。在正常人和兔动脉中,TFPI蛋白和mRNA在外膜层被检测到,但在内皮腔中未检测到。在兔的中膜平滑肌层中,检测到TFPI mRNA的弱表达,但未检测到蛋白;在人的中膜平滑肌层中,TFPI mRNA和蛋白均未检测到。在动脉粥样硬化动脉中,在接受内膜切除术患者的六个颈内动脉斑块中的三个中检测到TFPI蛋白和mRNA,在另一个标本中仅检测到mRNA。在斑块中TF丰富且与巨噬细胞共定位的区域发现了TFPI蛋白,表明这些细胞负责TFPI的合成。在19只高胆固醇饮食喂养4至16周的兔子的18只中,在脂肪条纹病变中也检测到了TFPI蛋白和mRNA。在这些富含巨噬细胞的病变中,TFPI蛋白和mRNA的表达在斑块底部最为强烈。这些研究表明,TFPI在大动脉的外膜层表达,并且在动脉粥样硬化血管中,TFPI在整个斑块的局部区域由巨噬细胞表达。TFPI的局部产生可能调节动脉粥样硬化斑块内的促凝血活性和血栓形成事件。

相似文献

1
Tissue factor pathway inhibitor expression in atherosclerosis.组织因子途径抑制剂在动脉粥样硬化中的表达
Lab Invest. 1997 Oct;77(4):291-8.
2
Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.组织因子与组织因子途径抑制物在冠状动脉粥样硬化中的共定位
J Pathol. 1999 Jun;188(2):180-8. doi: 10.1002/(SICI)1096-9896(199906)188:2<180::AID-PATH338>3.0.CO;2-Q.
3
Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels.组织因子途径抑制剂在正常及动脉粥样硬化人血管中的表达、定位与活性
Arterioscler Thromb Vasc Biol. 2000 May;20(5):1362-73. doi: 10.1161/01.atv.20.5.1362.
4
Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques.组织因子、组织因子途径抑制物与血管内皮生长因子-A在颈动脉粥样硬化斑块中的作用
Eur J Vasc Endovasc Surg. 2005 Jul;30(1):41-7. doi: 10.1016/j.ejvs.2005.02.055.
5
Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology.循环单核细胞反映了富含脂质和钙化形态的颈动脉粥样硬化斑块中 TF 和 TFPI 表达的失衡。
Thromb Res. 2012 Apr;129(4):e134-41. doi: 10.1016/j.thromres.2011.11.044. Epub 2011 Dec 15.
6
Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerotic lesions.极低密度脂蛋白受体mRNA在兔动脉粥样硬化病变中的表达。
Am J Pathol. 1996 Dec;149(6):1831-8.
7
Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions.动脉粥样硬化的免疫学。人类动脉粥样硬化病变中热休克蛋白60表达及携带α/β或γ/δ受体的T淋巴细胞的证实。
Am J Pathol. 1993 Jun;142(6):1927-37.
8
Lysophosphatidylcholine decreases the synthesis of tissue factor pathway inhibitor in human umbilical vein endothelial cells.溶血磷脂酰胆碱可降低人脐静脉内皮细胞中组织因子途径抑制物的合成。
Thromb Haemost. 1998 Jan;79(1):217-21.
9
Expression of tissue factor pathway inhibitor (TFPI) in human breast and colon cancer tissue.组织因子途径抑制剂(TFPI)在人乳腺癌和结肠癌组织中的表达。
Thromb Haemost. 2010 Jan;103(1):198-204. doi: 10.1160/TH09-06-0416. Epub 2009 Sep 30.
10
Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and von Willebrand factor in normal human tissues.组织因子途径抑制剂、血栓调节蛋白和血管性血友病因子在正常人体组织中的转录表达。
Thromb Haemost. 1999 Sep;82(3):1047-52.

引用本文的文献

1
Clinical significance of expression of tissue factor and tissue factor pathway inhibitor in ulcerative colitis.组织因子和组织因子途径抑制剂在溃疡性结肠炎中的表达的临床意义
World J Gastroenterol. 2014 Jun 21;20(23):7461. doi: 10.3748/wjg.v20.i23.7461.
2
Prothrombotic profile in patients with vasospastic or non vasospastic angina and non significant coronary stenosis.有痉挛性心绞痛或非痉挛性心绞痛但冠状动脉狭窄不显著的患者的血栓前状态。
Thromb J. 2011 May 27;9:10. doi: 10.1186/1477-9560-9-10.
3
Vascular-directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque development.
血管定向组织因子途径抑制剂过表达可调节血浆胆固醇并减少动脉粥样硬化斑块形成。
Circ Res. 2009 Sep 25;105(7):713-20, 8 p following 720. doi: 10.1161/CIRCRESAHA.109.195016. Epub 2009 Aug 27.
4
Plasma tissue factor pathway inhibitor levels in patients with acute pancreatitis.急性胰腺炎患者血浆组织因子途径抑制物水平
J Gastroenterol. 2009;44(10):1071-9. doi: 10.1007/s00535-009-0096-9. Epub 2009 Jun 30.
5
Tissue factor pathway inhibitor, vascular risk factors and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.组织因子途径抑制剂、血管风险因素与亚临床动脉粥样硬化:动脉粥样硬化的多种族研究。
Atherosclerosis. 2009 Nov;207(1):277-83. doi: 10.1016/j.atherosclerosis.2009.04.024. Epub 2009 Apr 24.
6
Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis.动脉粥样硬化、炎症与血栓形成三联征的不断演变的概念
J Thromb Thrombolysis. 2004 Feb;17(1):35-44. doi: 10.1023/B:THRO.0000036027.39353.70.
7
Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.基质金属蛋白酶-8降解后组织因子途径抑制物的结构与功能特征
Biochem J. 2002 Oct 15;367(Pt 2):451-8. doi: 10.1042/BJ20020696.